Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

BACKGROUND: The prioritization of U.S. health care personnel for early receipt of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), allowed for the evaluation of the effectiveness of these ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilishvili, Tamara, Gierke, Ryan, Fleming-Dutra, Katherine E., Farrar, Jennifer L., Mohr, Nicholas M., Talan, David A., Krishnadasan, Anusha, Harland, Karisa K., Smithline, Howard A., Hou, Peter C., Lee, Lilly C., Lim, Stephen C., Moran, Gregory J., Krebs, Elizabeth, Steele, Mark T., Beiser, David G., Faine, Brett, Haran, John P., Nandi, Utsav, Schrading, Walter A., Chinnock, Brian, Henning, Daniel J., Lovecchio, Frank, Lee, Jane, Barter, Devra, Brackney, Monica, Fridkin, Scott K., Marceaux-Galli, Kaytlynn, Lim, Sarah, Phipps, Erin C., Dumyati, Ghinwa, Pierce, Rebecca, Markus, Tiffanie M., Anderson, Deverick J., Debes, Amanda K., Lin, Michael Y., Mayer, Jeanmarie, Kwon, Jennie H., Safdar, Nasia, Fischer, Marc, Singleton, Rosalyn, Chea, Nora, Magill, Shelley S., Verani, Jennifer R., Schrag, Stephanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482809/
https://www.ncbi.nlm.nih.gov/pubmed/34551224
http://dx.doi.org/10.1056/NEJMoa2106599

Ejemplares similares

Ejemplares similares